Coronavirus (COVID-19): visiting The Royal Marsden suspended

Coronavirus (COVID-19) latest: Visiting The Royal Marsden is still suspended, but we want to reassure our patients, their families and anyone worried about cancer during this difficult time that we are still delivering treatment - the hospital is open. Please see more information here about how we are keeping everyone safe.

Clinical Genomics - Our service

We provide an extensive repertoire of genomic testing across cutting edge technology, resulting in accurate profiling of solid tumours and haematological malignancies, directing novel treatment strategies, personalised to the patient.

NHS England has created a Genomic Medicine Service to prepare the NHS to harness the power of genomic technology and science to improve the health of our population. Testing is now being delivered through single national testing network of seven Genomic Laboratory Hubs (GLHs). As part of The North Thames Genomic Laboratory Hub (GLH) we deliver consolidated somatic testing for cancer, whilst Great Ormond Street Hospital offers specialist rare and inherited genetic testing. The collaboration is led by Great Ormond Street Hospital (GOSH) and includes laboratories at Barts Health, University College Hospital and the Royal Free Hospital, the Royal National Orthopaedic Hospital, Imperial College Hospital and the Royal Marsden. 

What is Clinical Genomics?

Clinical Genomics can identify genetic changes in individual cancers, by using a variety of molecular and cytogenetic techniques, that make tumours susceptible to targeted treatments and which can lead to improved and personalised treatment for patients.

Why choose RMH Clinical Genomic Service?

The Royal Marsden, together with The Institute of Cancer Research, is the largest comprehensive cancer centre in Europe. 

Situated in the state-of-the art Centre for Molecular Pathology and working closely with our translational research team means we are at the forefront of applying new technologies to cancer care and can rapidly translate novel genomic tests and technologies into the diagnostic setting. Our laboratories are UKAS accredited (United Kingdom Accreditation Service) providing valuable assurance that our services are technically competent, and our organisation has been assessed to an internationally recognised standard. 

Close interaction with world leading experts in basic and translational research, pathologists & oncologists, across the North Thames Genomic Laboratory Hub, offers a unique environment for cancer research and clinical care. 

How to refer?

For details on how to refer please contact us.

For further information on the services offered please see our Service Specification guide.


Our leading edge technology helps us to accelerate our research from the laboratory into the clinic and enables us to offer a truly personalised approach for cancer patients everywhere.